ADVENT On Air

Disease Modification in Severe Asthma: Framework, Assessment, and Clinical Impact

2026-01-30

Join Profs. Brusselle and Backer as they discuss the concept of disease modification in asthma. Join them as they highlight the concept of disease modification in severe asthma, how it can be defined and objectively assessed, and the benefits for the patient when disease modification is a treatment target.



ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. 



This podcast is intended for healthcare professionals only.



Disclaimer:


This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program

The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


Speaker disclosures:


Dr. Vibeke Backer: has worked as an advisor, supervisor, and investigator of pharmaceutical studies and has received unrestricted grants from AstraZeneca, GSK, MSD & Schering Plough, ALK-Abelló, Nycomed, Chiesi, Novartis, Pharmaxis, Nigaard, Pfizer, Boehringer Ingelheim, Maribo Medico, Aerocrine, Teva, Sanofi, Regeneron, and BIRK NPC.

Dr. Guy Bruselle: has received grants from Merck Sharp & Dohme and has recevied lecturer/consultant fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, and Sanofi




© 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

MAT-GLB-2503097 - 1.0 - 01/2026

MAT-US-2600873 v1.0 - P Expiration Date: 01/28/2028

Número de episodios

28

Último episodio

2026-10-08

¿Donde puedes escuchar?

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field.
The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area.
Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com.
This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals.

©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2302644 v2.0 07/2023
MAT-US-2304947 v1.0-P Exp. Date 07/07/2025